Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Visual field defect
ADR ID BADD_A04594
ADR Hierarchy
06      Eye disorders
06.02      Vision disorders
06.02.07      Visual field disorders
06.02.07.003      Visual field defect
17      Nervous system disorders
17.17      Neurological disorders of the eye
17.17.01      Neurologic visual problems NEC
17.17.01.001      Visual field defect
Description A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions. | A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA), OPTIC NERVE DISEASES, and other conditions. [MeSH]
MedDRA Code 10047555
MeSH ID D012607
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Arcuate scotoma | Blind spot enlarged | Central scotoma | Defect visual field (NOS) | Generalized visual field contraction or constriction | Mariotte's spot enlarged | Other localized visual field defect | Peripheral vision defective | Scotoma | Scotoma annular | Scotoma central | Scotoma involving central area | Scotoma of blind spot area | Scotoma peripheral | Scotoma transient | Sector or arcuate visual field defects | Vision central defective | Vision peripheral decreased | Vision peripheral defective | Visual field constriction | Visual field defect | Visual field defect NOS | Visual field defect, unspecified | Visual field defects | Bilateral visual field constriction | Scotomas | Scotoma, Arcuate | Arcuate Scotoma | Arcuate Scotomas | Scotomas, Arcuate | Scotoma, Bjerrum | Bjerrum Scotoma | Bjerrum Scotomas | Scotomas, Bjerrum | Scotoma, Central | Central Scotoma | Central Scotomas | Scotomas, Central | Scotoma, Sector | Scotomas, Sector | Sector Scotoma | Sector Scotomas | Scotoma, Paracecal | Paracecal Scotoma | Paracecal Scotomas | Scotomas, Paracecal | Scotoma, Paracentral | Paracentral Scotoma | Paracentral Scotomas | Scotomas, Paracentral | Scotoma, Peripheral | Peripheral Scotoma | Peripheral Scotomas | Scotomas, Peripheral | Scotoma, Ring | Ring Scotoma | Ring Scotomas | Scotomas, Ring | Scotoma, Scintillating | Scintillating Scotoma | Scintillating Scotomas | Scotomas, Scintillating | Scotoma, Altitudinal | Altitudinal Scotoma | Altitudinal Scotomas | Scotomas, Altitudinal | Scotoma, Centrocecal | Centrocecal Scotoma | Centrocecal Scotomas | Scotomas, Centrocecal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02247Topiramate0.000312%
BADD_D02265Travoprost0.000404%
BADD_D02270Tretinoin--
BADD_D02272Triamcinolone acetonide0.000150%
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02316Unoprostone--
BADD_D02317Unoprostone isopropyl--
BADD_D02329Valproic acid0.000100%
BADD_D02335Vardenafil--
BADD_D02336Vardenafil hydrochloride--
BADD_D02337Varenicline0.000428%
BADD_D02338Varenicline tartrate--
BADD_D02346Venlafaxine0.000109%
BADD_D02352Verteporfin--
BADD_D02355Vigabatrin0.003699%
BADD_D02360Vincristine0.000168%
BADD_D02367Voltaren--
BADD_D02369Voriconazole0.040660%
BADD_D02379Zaleplon--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02393Zolmitriptan0.001015%
BADD_D02396Zonisamide--
BADD_D02412Octreotide0.000279%
BADD_D02464Fingolimod0.007788%
BADD_D02473Sodium chloride0.000241%
BADD_D02511Siponimod0.000892%
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages